TDC
EXAS

Thompson Davis & Co’s Exact Sciences EXAS Stock Holding History

Thompson Davis & Co’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$8K Sell
100
-25
-20% -$1.63K 0.02% 489
2018
Q2 		$7K Buy
+125
New +$6.73K 0.02% 473
2018
Q1 		– Sell
-1,250
Closed -$66K – 654
2017
Q4 		$66K Sell
1,250
-500
-29% -$26.7K 0.16% 145
2017
Q3 		$82K Hold
1,750
– – 0.15% 156
2017
Q2 		$62K Buy
+1,750
New +$54K 0.1% 190
2016
Q4 		– Sell
-250
Closed -$5K – 1141
2016
Q3 		$5K Hold
250
– – 0.01% 825
2016
Q2 		$3K Buy
+250
New +$1.88K ﹤0.01% 878
2015
Q2 		– Sell
-125
Closed -$3K – 1205
2015
Q1 		$3K Sell
125
-3,625
-97% -$92K ﹤0.01% 1010
2014
Q4 		$103K Buy
3,750
+3,625
+2,900% +$88.2K 0.12% 178
2014
Q3 		$2K Sell
125
-125
-50% -$2.29K ﹤0.01% 1049
2014
Q2 		$4K Buy
+250
New +$3.44K 0.01% 636

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thompson Davis & Co's EXAS Position: Q3 2018 in Review

Thompson Davis & Co reduced its Exact Sciences (EXAS) stake by 20% in Q3 2018, selling an estimated $1.63K and leaving 100 shares worth $8K. The position accounts for 0.02% of the portfolio, ranked #489.

Thompson Davis & Co first reported a position in EXAS in Q2 2014 and has held it in 11 quarters since. The position peaked at $103K in Q4 2014. 364 funds tracked by Wall St. Rank hold EXAS as of Q3 2018.

  • Thompson Davis & Co held 100 shares of Exact Sciences worth $8K as of Q3 2018.
  • Thompson Davis & Co sold 25 Exact Sciences shares in Q3 2018, an estimated $1.63K.
  • Exact Sciences made up 0.02% of Thompson Davis & Co's portfolio in Q3 2018, its #489 holding.
  • Thompson Davis & Co first reported a position in Exact Sciences in Q2 2014 and has held it in 11 quarters since.
  • Thompson Davis & Co's Exact Sciences position peaked at $103K in Q4 2014.
  • 364 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.